Background-Interleukin-10 (IL-10) is an 18 kDa peptide with a range of antiinflammatory and immunosuppressive properties. Aim-To determine whether this cytokine is involved in gastric mucosal inflammation in Helicobacterpylori infection.
tion in Helicobacterpylori infection.
Methods-The production of IL-10 by antral mucosal biopsy specimens during short term in vitro culture was determined by measuring IL-10 content of supernatants by enzyme linked immunosorbant assay (ELISA). H pyloon status was determined by serology and histology, with gastritis scored using the Sydney system. Tumour necrosis factor-a (TNF-ae) content of supernatants was also determined in a subgroup ofpatients. Results-IL-10 secretion was significantly greater in patients with H pylon associated chronic gastritis than in patients who were H pylori negative with normal mucosa/reactive changes, and those with Hpylori negative chronic gastritis (p<001 and <0.05 respectively). There was a significant correlation overall between IL-10 secretion and chronic inflammation score (r=0.40). Secretion of TNF-a, which was significantly higher in H pylon infected patients than uninfected patients with a normal mucosa (p<0.04), correlated with scores for chronic inflammation and activity (r=0.39 and 0-38 respectively), but was only weakly correlated with IL-10 secretion (r=0.22, NS). Conclusions-Gastric mucosal production of IL-10 and TNF-ct are increased in chronic gastritis associated with H pylon infection, and mucosal cytokine secretion varies with important histopathological aspects of gastric inflammation. Whereas the secretion of IL-10 in Hpylon infection may be protective, limiting tissue damage caused by inflammation, it may also contribute towards failure of the immune response to eliminate the organism. (Gut 1997; 40: [739] [740] [741] [742] [743] [744] Keywords: interleukin-10, Helicobacterpylori, tumour necrosis factor--a.
Histologically, chronic gastritis associated with Helicobacter pylori is characterised by infiltration of the lamina propria by chronic inflammatory cells, the presence of lymphoid follicles, and a variable degree of polymorph infiltration indicative of active inflammation.' The presence of this inflammatory infiltrate suggests a specific immune response directed against the organism. Local cellular immunity, as judged by cytokine production, seems to be activated, with in vitro biopsy studies showing raised mucosal production of proinflammatory cytokines, such as interleukin (IL)-1, IL-6, and IL-8, tumour necrosis factor-a (TNF-a), and interferon--y (IFN-y) in subjects with H pylon associated gastritis.`25 Short term biopsy cultures have also confirmed a local humoral response in infected patients, with in vitro mucosal production of H pylori specific immunoglobulins.6 Despite this evidence for an intact mucosal immune response to Hpylori infection, most people fail to eliminate the organism spontaneously, with infection persisting long term. Although there are probably many factors which contribute to the chronicity of infection, immune suppression or down regulation of local immune reactions is likely to play a part.7 8 Bacterial induced immunomodulation, mediated via the release of "inhibitory" cytokines, may contribute to this process. Interleukin-10 (IL-10) is an 18 kDa peptide that was initially described as "cytokine synthesis inhibitory factor" because of its ability to suppress cytokine synthesis in certain T cells.9 Specifically, IL-10 suppressed IFN--y and IL-2 production by Thl cells. Although initially described as a product of the Th2 subset of CD4+ helper cells, in humans IL-10 production has also been shown in ThO first incubated at room temperature in microtitre wells coated with a murine monoclonal antibody to human IL-10. After washing, a conjugate consisting of an enzyme linked polyclonal antibody specific for interleukin-10 was added to the wells, to sandwich the IL-10 immobilised during the first incubation. Wells were subsequently washed, and a colour reagent (tetramethyl benzidine plus hydrogen peroxide) added. Colour development was stopped using 2N sulphuric acid, and the optical density of each well determined with a spectrophotometer set at 450 nm (wavelength correction 540 nm). Sample concentration of IL-10 was determined from a standard curve obtained by assaying a dilution series of recombinant human IL-10 (R&D Systems). For culture media samples the reported sensitivity of the assay was 1-5 pg/ml, and no cross reactivity with other cytokines has been found.
TUMOUR NECROSIS FACTOR-CX ASSAY
Content of TNF-a in culture supernatants was also assayed in duplicate using a commercial ELISA (Genzyme diagnostics, Cambridge, USA) in a subgroup of patients (n=34). Samples were incubated in microtitre wells coated with monoclonal antibody to human TNF-a. After washing, a conjugate consisting of a biotin labelled polyclonal antibody to TNF-a was added to the wells, to bind the captured TNF-a. Wells were then washed, and a peroxidase labelled streptavidin reagent added which attaches to biotin in the immune complex on the plate. After a further wash, a substrate (peroxide) and chromogen (tetramethyl benzidine) were added, and colour development was stopped with IM sulphuric acid. The optical density of each well was determined with a spectrophotometer set at 450 nm, and sample concentration of TNF-ot was determined from a standard curve. For culture media samples the reported sensitivity of the assay was 10 pg/ml, and no cross reactivity with other cytokines has been seen.
DETERMINATION OF H PYLORI STATUS
The presence or absence of H pylon was identified histologically using Giemsa staining.
H pylon serology was determined using a commercial ELISA kit for H pylon speci- Figure 1 and Table II Fig 4) . Secretion of TNF-ot was significantly correlated with inflammation score and activity score (r=0-39 and 0-38 respectively).
Discussion
We have successfully measured in vitro IL-10 secretion from normal and inflamed gastric ' The finding of higher secretion of both IL-10 and TNF-ot in H pylon positive versus H pylon negative chronic gastritis in the present study may simply reflect differences in the degree of inflammation between our groups, rather than indicating a specific feature of gastric immune responses to the organism. To allow for the various theoretical sources of IL-10 within inflamed gastric mucosa, we examined in vitro secretion from whole biopsy specimens. Hence the cellular source of IL-10 in our study is unknown. Although in mice the Th2 subset of CD4+ lymphocytes is classically is interesting to speculate about the possible role of this immunoregulatory cytokine in the local immune response to H pylon infection, and to its possible influence on disease manifestations. We do not know whether the secretion of IL-1 0 in H pylon gastritis simply represents physiological anti-inflammatory activity, or dysregulation of cytokines in the inflamed mucosa. The first is perhaps the most likely, with IL-10 serving a protective role, reducing local tissue damage caused by inflammation. In vitro, IL-10 inhibits the production of a wide range of proinflammatory molecules and chemokines, such as IL-1, IL-6, and IL-8, TNF-ot, and IFN--y,"1 13-15 all of which have been implicated in H pylon associated gastritis. 2 We did not find any strong correlation between absolute IL-10 secretion and that of TNF-ot, although both were correlated with chronic inflammatory cell scores. Clearly the level of activation of mucosal immune cells, the relative proportions of different cell phenotypes, and the presence of other inflammatory mediators will influence the quantity of cytokine secreted rather than cell numbers alone. In addition to damping down local inflammation, the secretion of IL-10 may also contribute to the failure of the immune response to eliminate H pyloni infection. To survive, the organism may have evolved the propensity to suppress partially the local immune response. Knipp et al have reported a dose dependent reduction in peripheral blood mononuclear cell proliferative responses to mitogen produced by extracts of H pylori, suggesting that the bacterium possesses immunosuppressive properties.8 Furthermore, Karttunen et al have found slightly lower H pylon induced DNA synthesis and IFN--y production by peripheral blood mononuclear cells from H pylon infected subjects than for uninfected subjects,28 suggesting that perhaps immune responses to the bacterium are attenuated in chronic infection. H pylon induced secretion of immune suppressive cytokines, such as IL-10, may partly explain these phenomena. Secretion of IL-10 has been implicated as a factor associated with adverse disease outcome in bacterial infections. For example, in a murine model of Kiebsiella pneumonia, inhibition of IL-10 bioactivity in vivo resulted in enhanced bacterial clearance, increased expression of proinflammatory cytokines, and prolonged survival. 29 Furthermore, in vivo, the induction of IL-10 synthesis during certain parasitic infections has been suggested as an important strategy by which parasites evade immune destruction.'0 Impaired antitumour immunity has also been associated with IL-10."' 32 It could be postulated that H pylori induced IL-10 production, although having the beneficial effect of limiting inflammation in chronic gastritis, could also render local mucosal immune cells less able to mount an adequate defence against malignant cells. There is accumulating evidence to implicate H pylori infection as a cofactor in gastric cancer," and local immunosuppressive cytokine production in chronic gastritis may provide a further mechanism by which the organism may predispose to the development or progression of malignancy.
In summary, we have shown raised mucosal secretion of IL-10 and TNF-a in H pylori gastritis, with gastric cytokine secretion being higher in patients with more severe chronic inflammation. Whereas the release of IL-10 may be protective, limiting tissue damage caused by inflammation, IL-10 may also contribute to failure of the immune response to eliminate the organism. The effects of IL-10 on the gastric immune response to Hpylori, as well as possible implications in gastric cancer, require further investigation.
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